Orchestra BioMed Holdings, Inc. (OBIO) stock
OBIONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$6.97−0.15 (-2.11%)
Close on Nov 17, 2026Market cap $418.93MP/E –Yield –
Orchestra BioMed operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Orchestra BioMed's operating cash flow for the twelve months ending Jun 30, 2026 was -$58.32M. For fiscal 2025 it was -$48.96M. The highest annual figure on record is -$272.36K in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$48.96M | – |
| FY2024 | Dec 31, 2024 | -$50.56M | – |
| FY2023 | Dec 31, 2023 | -$46.13M | – |
| FY2022 | Dec 31, 2022 | -$29.29M | – |
| FY2021 | Dec 31, 2021 | -$272.36K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$19.33M | – |
| Q1 FY2026 | Mar 31, 2026 | -$22.17M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.27M | – |
| Q3 FY2025 | Sep 30, 2025 | -$14.55M | – |
| Q2 FY2025 | Jun 30, 2025 | -$15.53M | – |
| Q1 FY2025 | Mar 31, 2025 | -$16.62M | – |
| Q4 FY2024 | Dec 31, 2024 | -$13.54M | – |
| Q3 FY2024 | Sep 30, 2024 | -$13.70M | – |
| Q2 FY2024 | Jun 30, 2024 | -$10.21M | – |
| Q1 FY2024 | Mar 31, 2024 | -$13.11M | – |
| Q4 FY2023 | Dec 31, 2023 | -$10.97M | – |
| Q3 FY2023 | Sep 30, 2023 | -$10.28M | – |
| Q2 FY2023 | Jun 30, 2023 | -$10.49M | – |
| Q1 FY2023 | Mar 31, 2023 | -$14.38M | – |
| Q4 FY2022 | Dec 31, 2022 | -$8.74M | – |
| Q3 FY2022 | Sep 30, 2022 | -$7.26M | – |
| Q2 FY2022 | Jun 30, 2022 | -$7.97M | – |
| Q1 FY2022 | Mar 31, 2022 | -$5.32M | – |
| Q4 FY2021 | Dec 31, 2021 | -$28.84K | – |
| Q3 FY2021 | Sep 30, 2021 | -$128.01K | – |
| Q2 FY2021 | Jun 30, 2021 | -$39.14K | – |
| Q1 FY2021 | Mar 31, 2021 | -$76.37K | – |
See a number that looks wrong?